Highlights Procaps Group S.A.

Equities

PROC

LU2376511205

Market Closed - Nasdaq Other stock markets 21:30:00 15/05/2024 BST			5-day change	1st Jan Change
2.59 ^USD	-5.82%		-4.78%	-36.36%

05-01	Procaps Group S.A. Provides Earnings Guidance for the Year Ended December 31, 2023	CI
03-04	Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Procaps Group S.A. Provides Earnings Guidance for the Year Ended December 31, 2023	05-01	CI
Procaps Group S.A. Provides Earnings Guidance for the Full Year 2023	12-26	CI
Procaps Group S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	12-26	CI
Tranche Update on Procaps Group S.A.'s Equity Buyback Plan announced on June 1, 2023.	12-26	CI
Procaps Group Teams Up With Genomma Lab to Manufacture, Market Softgel Products in Latin America	11-30	MT
Procaps Group and Genomma Lab Announce Strategic Agreement to Manufacture and Market Softgel Products in Latin America	11-29	CI
Procaps Group, S.A. Announces the Expansion of Its Oncology Portfolio	07/09/23	CI
Earnings Flash (PROC) PROCAPS GROUP S.A. Posts Q2 Revenue $110M	05/09/23	MT
Procaps Group S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	05/09/23	CI
Procaps Group S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	06/06/23	CI
Procaps Group Q1 Earnings, Revenue Decline	06/06/23	MT
Procaps Group S.A. commences an Equity Buyback Plan for 11,282,418 shares, representing 10% of its issued share capital, under the plan approved on June 28, 2022.	31/05/23	CI
(PROC) PROCAPS GROUP S.A. Forecasts Q1 Revenue Range $82M - $85M	12/05/23	MT
Earnings Flash (PROC) PROCAPS GROUP S.A. Reports Q4 Revenue $101.5M	12/05/23	MT
Procaps Group S.A. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2023	12/05/23	CI
Procaps Group S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	12/05/23	CI
Procaps Group S.A. Provides Earnings Guidance for the Fiscal Year Ended December 31, 2022 and 2023	13/02/23	CI
Procaps Group S.A. authorizes a Buyback Plan.	12/02/23	CI
Procaps Group Terminates Proposed Acquisition of Grupo Somar	04/01/23	MT
Procaps Group S.A. cancelled the acquisition of Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.	02/01/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Procaps Group S.A.

Equities

PROC

LU2376511205

Highlights

Filters